BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9661591)

  • 1. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors.
    Carling T; Rastad J; Akerström G; Westin G
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2255-9. PubMed ID: 9661591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels.
    Correa P; Rastad J; Schwarz P; Westin G; Kindmark A; Lundgren E; Akerström G; Carling T
    J Clin Endocrinol Metab; 1999 May; 84(5):1690-4. PubMed ID: 10323401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism.
    Carling T; Ridefelt P; Hellman P; Rastad J; Akerström G
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1772-5. PubMed ID: 9177380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T; Rastad J; Szabó E; Westin G; Akerström G
    J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
    Correa P; Akerstrom G; Westin G
    Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids.
    Russell J; Bar A; Sherwood LM; Hurwitz S
    Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians.
    Varshney S; Bhadada SK; Saikia UN; Sachdeva N; Behera A; Arya AK; Sharma S; Bhansali A; Mithal A; Rao SD
    Eur J Endocrinol; 2013 Jul; 169(1):109-16. PubMed ID: 23660642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas.
    Samander EH; Arnold A
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5019-21. PubMed ID: 17003089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients.
    Nagaba Y; Heishi M; Tazawa H; Tsukamoto Y; Kobayashi Y
    Am J Kidney Dis; 1998 Sep; 32(3):464-9. PubMed ID: 9740163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Possible Link Between Parathyroid Hormone Secretion and Local Regulation of GABA in Human Parathyroid Adenomas.
    Hong AR; Kim YA; Bae JH; Min HS; Kim JH; Shin CS; Kim SY; Kim SW
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2594-601. PubMed ID: 27070188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor gene polymorphism and parathyroid calcium sensor protein (CAS/gp330) expression in primary hyperparathyroidism.
    Carling T; Ridefelt P; Hellman P; Juhlin C; Lundgren E; Akerström G; Rastad J
    World J Surg; 1998 Jul; 22(7):700-6; discussion 706-7. PubMed ID: 9606285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apa I polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease.
    Yokoyama K; Shigematsu T; Tsukada T; Ogura Y; Takemoto F; Hara S; Yamada A; Kawaguchi Y; Hosoya T
    Kidney Int; 1998 Feb; 53(2):454-8. PubMed ID: 9461106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor genotypes in primary hyperparathyroidism.
    Carling T; Kindmark A; Hellman P; Lundgren E; Ljunghall S; Rastad J; Akerström G; Melhus H
    Nat Med; 1995 Dec; 1(12):1309-11. PubMed ID: 7489414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BsmI vitamin D receptor polymorphism and pathogenesis of parathyroid adenoma.
    Pacheco D; Menárguez J; Cristobal E; Arribas B; Alcazar JA; Carrión R; Polo JR
    Med Sci Monit; 2000; 6(4):658-60. PubMed ID: 11208387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor alleles b, a, and T: risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1.
    Carling T; Kindmark A; Hellman P; Holmberg L; Akerström G; Rastad J
    Biochem Biophys Res Commun; 1997 Feb; 231(2):329-32. PubMed ID: 9070272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
    Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of relationship between BsmI vitamin D receptor polymorphism and primary hyperparathyroidism in a Spanish female population.
    Menárguez J; Goicoechea M; Crist bal E; Arribas B; Martínez ME; Alcázar JA; Carri n R; Polo JR
    Calcif Tissue Int; 1999 Sep; 65(3):214-6. PubMed ID: 10441653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous changes in the calcium-sensing receptor and the vitamin D receptor under the influence of calcium and calcitriol.
    Carrillo-López N; Alvarez-Hernández D; González-Suárez I; Román-García P; Valdivielso JM; Fernández-Martín JL; Cannata-Andía JB
    Nephrol Dial Transplant; 2008 Nov; 23(11):3479-84. PubMed ID: 18556746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation.
    Giannini S; D'Angelo A; Nobile M; Carraro G; Rigotti P; Silva-Netto F; Pavan S; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
    J Bone Miner Res; 2002 Oct; 17(10):1768-73. PubMed ID: 12369780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas.
    Varshney S; Bhadada SK; Sachdeva N; Arya AK; Saikia UN; Behera A; Rao SD
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1631-5. PubMed ID: 23913941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.